DocGo Inc. (NASDAQ:DCGO) Stock Has Average Price Target of $2.38

DocGo Inc. (NASDAQ:DCGO) has been given an average recommendation of “Hold” by the six analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $2.38.

A number of research analysts have recently commented on DCGO shares. Needham & Company LLC reiterated a “buy” rating on shares of DocGo in a research report on Wednesday. Canaccord Genuity Group restated a “hold” rating and issued a $1.00 price target on shares of DocGo in a research report on Tuesday, August 18th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th.

DocGo Stock Performance

Shares of NASDAQ DCGO opened at $0.40 on Friday. The company has a market cap of $39.55 million, a P/E ratio of -0.20 and a beta of 0.94. The firm’s fifty day moving average is $0.48 and its two-hundred day moving average is $0.56. DocGo has a 52-week low of $0.31 and a 52-week high of $1.65.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.06). DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%.The company had revenue of $73.42 million during the quarter, compared to analysts’ expectations of $75.35 million. As a group, analysts forecast that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Trading of DocGo

Several hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC raised its position in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after purchasing an additional 944,826 shares during the period. S Squared Technology LLC purchased a new position in DocGo during the second quarter worth $1,060,725. BlackRock Inc. bought a new position in DocGo during the 2nd quarter valued at about $750,000. Empowered Funds LLC purchased a new stake in shares of DocGo in the second quarter worth approximately $79,000. Finally, Ieq Capital LLC purchased a new stake in DocGo in the second quarter worth $126,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

About DocGo

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.